MSC Exosomes for Diabetic Wound Care
Diabetic and chronic wounds are a major focus of MSC-derived exosome research. This overview is for research and educational purposes only.
What MSC exosomes are
MSC-derived exosomes are nanoscale, cell-free extracellular vesicles carrying signaling cargo such as proteins, lipids, and microRNA. BioRegenEx supplies characterized, research-use-only material with per-lot documentation.
What the research explores
In preclinical diabetic-wound and chronic-wound models, MSC-derived exosomes have been studied for signaling related to angiogenesis, inflammation, and tissue repair. These are research findings only. The studies are indexed in our Exosome Research Library under Skin, Wound & Hair and Metabolic & Diabetic.
Key Published Research
Human clinical evidence listed first, then preclinical. Every entry links to its PubMed record.
- Injection of human umbilical cord mesenchymal stem cell exosomes for the treatment of knee osteoarthritis: from preclinical to clinical research. J Transl Med, 2025. HUMAN randomized controlled trial. (PubMed)
- Anti-inflammatory and immunomodulatory effects of extracellular vesicles derived from human umbilical cord mesenchymal stem cells on osteoarthritis. J Nanobiotechnology, 2022. Preclinical. (PubMed)
- The potential use of mesenchymal stem cells and their derived exosomes for orthopedic diseases treatment. Stem Cell Rev Rep, 2022. Review. (PubMed)
- Safety and efficacy of placental mesenchymal stromal cell-derived extracellular vesicles in knee osteoarthritis. BMC Musculoskelet Disord, 2024. HUMAN clinical trial. (PubMed)
- Clinical-grade extracellular vesicles derived from umbilical cord mesenchymal stem cells for osteoarthritis. J Nanobiotechnology, 2025. Preclinical. (PubMed)
- Mesenchymal stromal cell-based therapy for cartilage regeneration in knee osteoarthritis. Stem Cell Res Ther, 2022. Review. (PubMed)
- Harnessing tissue-derived extracellular vesicles for osteoarthritis theranostics. Theranostics, 2022. Review. (PubMed)
Sourcing considerations
Look for characterized lots, sterility and endotoxin screening, cold-chain handling, and clear research-use-only labeling. See our overview of MSC exosomes for wound healing.
Frequently Asked Questions
Are MSC exosomes an approved treatment for diabetic wounds?
No. They are not FDA-approved to treat diabetic wounds or any condition and are supplied for research use only (RUO).
What does the wound research focus on?
Preclinical research focuses on angiogenesis, inflammation, and tissue-repair signaling in wound models.
For research and educational purposes; research-use-only.
These statements have not been evaluated by the FDA. BioRegenEx supplies MSC-derived exosomes for research use only (RUO); they are not intended to diagnose, treat, cure, or prevent any disease. This content is educational and is not medical advice.